Exelixis executives Schwab, Berndt pass away
Plus: bluebird, ADC, Passage Bio and Insilico
Gisela Schwab, CMO and president of product development and medical affairs of Exelixis Inc. (NASDAQ:EXEL), passed away over the weekend. Schwab helped lead the cancer company’s transformation from R&D stage company to commercial biotech. The company also lost Jon Berndt, SVP of sales, to cancer on Wednesday. Berndt played a central role in building sales organization before the launch of Cabometyx cabozantinib. A search for the next CMO is ongoing.
Gina Consylman will become CFO at bluebird bio Inc. (NASDAQ:BLUE) after the company separates its cancer business into 2seventy bio in mid-October. Consylman, who joined the company in August as CFO of the severe genetic disease business, was CFO of Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), which went through a similar split. ...